相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。545. Transductionally-Retargeted Infectivity Selective Oncolytic Adenovirus with Redesigned AB-Loop Targeting Cell Surface Mesothelin
MOLECULAR THERAPY (2016)
Tunable Protease-Activatable Virus Nanonodes
Justin Judd et al.
ACS NANO (2014)
Efficiency of Protease-Activatable Virus Nanonodes Tuned Through Incorporation of Wild-Type Capsid Subunits
Michelle L. Ho et al.
CELLULAR AND MOLECULAR BIOENGINEERING (2014)
Systemic Image-Guided Liver Cancer Radiovirotherapy Using Dendrimer-Coated Adenovirus Encoding the Sodium Iodide Symporter as Theranostic Gene
Geoffrey K. Gruenwald et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Adenoviral Vectors Coated with PAMAM Dendrimer Conjugates Allow CAR Independent Virus Uptake and Targeting to the EGF Receptor
Alexandra Vetter et al.
MOLECULAR PHARMACEUTICS (2013)
Displaying High-affinity Ligands on Adeno-associated Viral Vectors Enables Tumor Cell-specific and Safe Gene Transfer
Robert C. Muench et al.
MOLECULAR THERAPY (2013)
An Adenovirus Vector Incorporating Carbohydrate Binding Domains Utilizes Glycans for Gene Transfer
Julius W. Kim et al.
PLOS ONE (2013)
In Vivo-Directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous
Deniz Dalkara et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Site-Specific Modification of Adeno-Associated Viruses via a Genetically Engineered Aldehyde Tag
Yarong Liu et al.
SMALL (2013)
SCHEMA Computational Design of Virus Capsid Chimeras: Calibrating How Genome Packaging, Protection, and Transduction Correlate with Calculated Structural Disruption
Michelle L. Ho et al.
ACS SYNTHETIC BIOLOGY (2013)
Conjugation of paclitaxel on adeno-associated virus (AAV) nanoparticles for co-delivery of genes and drugs
Fang Wei et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Directed Evolution of Adeno-associated Virus for Enhanced Gene Delivery and Gene Targeting in Human Pluripotent Stem Cells
Prashanth Asuri et al.
MOLECULAR THERAPY (2012)
The AAV Vector Toolkit: Poised at the Clinical Crossroads
Aravind Asokan et al.
MOLECULAR THERAPY (2012)
Endgame: Glybera Finally Recommended for Approval as the First Gene Therapy Drug in the European Union
Seppo Ylae-Herttuala
MOLECULAR THERAPY (2012)
Development of Peritoneal Tumor-Targeting Vector by In Vivo Screening with a Random Peptide-Displaying Adenovirus Library
Takeshi Nishimoto et al.
PLOS ONE (2012)
Random Insertion of mCherry Into VP3 Domain of Adeno-associated Virus Yields Fluorescent Capsids With no Loss of Infectivity
Justin Judd et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2012)
Enhanced Real-Time Monitoring of Adeno-Associated Virus Trafficking by Virus-Quantum Dot Conjugates
Kye-Il Joo et al.
ACS NANO (2011)
Engineering Liver-detargeted AAV9 Vectors for Cardiac and Musculoskeletal Gene Transfer
Nagesh Pulicherla et al.
MOLECULAR THERAPY (2011)
Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B
Amit C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Katrin Knop et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Sites in the AAV5 capsid tolerant to deletions and tandem duplications
Kaoru Hida et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in vitro and in vivo
Sergey S. Seregin et al.
BLOOD (2010)
Progress in phage display: evolution of the technique and its applications
Tomaz Bratkovic
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Avidin-biotin technology in targeted therapy
Hanna P. Lesch et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library
Y. Ying et al.
GENE THERAPY (2010)
Physical adsorption of PEG grafted and blocked poly-L-lysine copolymers on adenovirus surface for enhanced gene transduction
Ji Won Park et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Retargeting of Adenovirus Vectors through Genetic Fusion of a Single-Chain or Single-Domain Antibody to Capsid Protein IX
Kathy L. Poulin et al.
JOURNAL OF VIROLOGY (2010)
Directed Evolution of a Novel Adeno-associated Virus (AAV) Vector That Crosses the Seizure-compromised Blood-Brain Barrier (BBB)
Steven J. Gray et al.
MOLECULAR THERAPY (2010)
Combination of adenovirus and cross-linked low molecular weight PEI improves efficiency of gene transduction
Jianfeng Han et al.
NANOTECHNOLOGY (2010)
Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle
Aravind Asokan et al.
NATURE BIOTECHNOLOGY (2010)
An adenoviral vector expressing human adenovirus 5 and 3 fiber proteins for targeting heterogeneous cell populations
Miho Murakami et al.
VIROLOGY (2010)
Genome-Free Viral Capsids as Multivalent Carriers for Taxol Delivery
Wesley Wu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
PEGylated Viral Nanoparticles for Biomedicine: The Impact of PEG Chain Length on VNP Cell Interactions In Vitro and Ex Vivo
Nicole F. Steinmetz et al.
BIOMACROMOLECULES (2009)
Putting Synthesis into Biology: A Viral View of Genetic Engineering through De Novo Gene and Genome Synthesis
Steffen Mueller et al.
CHEMISTRY & BIOLOGY (2009)
Re-targeted adenovirus vectors with dual specificity; binding specificities conferred by two different Affibody molecules in the fiber
S. Myhre et al.
GENE THERAPY (2009)
Efficient delivery of angiostatin K1-5 into tumors following insertion of an NGR peptide into adenovirus capsid
B. Jullienne et al.
GENE THERAPY (2009)
Engineering adeno-associated virus serotype 2-based targeting vectors using a new insertion site-position 453-and single point mutations
Jorge Boucas et al.
JOURNAL OF GENE MEDICINE (2009)
A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide
Kouki Morizono et al.
JOURNAL OF GENE MEDICINE (2009)
Heparin binding induces conformational changes in Adeno-associated virus serotype 2
Hazel C. Levy et al.
JOURNAL OF STRUCTURAL BIOLOGY (2009)
In Vivo Retargeting of Adenovirus Type 5 to αvβ6 Integrin Results in Reduced Hepatotoxicity and Improved Tumor Uptake following Systemic Delivery
Lynda Coughlan et al.
JOURNAL OF VIROLOGY (2009)
Molecular Evolution of Adeno-associated Virus for Enhanced Glial Gene Delivery
James T. Koerber et al.
MOLECULAR THERAPY (2009)
Synthetic viruses: a new opportunity to understand and prevent viral disease
Eckard Wimmer et al.
NATURE BIOTECHNOLOGY (2009)
A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection
Lin Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Adeno-associated virus-2 and its primary cellular receptor-Cryo-EM structure of a heparin complex
Jason O'Donnell et al.
VIROLOGY (2009)
In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses
Dirk Grimm et al.
JOURNAL OF VIROLOGY (2008)
Site-specific modification of AAV vector particles with biophysical probes and targeting ligands using biotin ligase
Matthew D. Stachler et al.
MOLECULAR THERAPY (2008)
Engineering and selection of shuffled AAV genomes: A new strategy for producing targeted biological nanoparticles
Wuping Li et al.
MOLECULAR THERAPY (2008)
DNA shuffling of adeno-associated virus yields functionally diverse viral progeny
James T. Koerber et al.
MOLECULAR THERAPY (2008)
Targeted cell entry of lentiviral vectors
Sabrina Funke et al.
MOLECULAR THERAPY (2008)
Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia
Sean E. Hofherr et al.
HUMAN GENE THERAPY (2007)
Self-assembled virus-like particles with magnetic cores
Xinlei Huang et al.
NANO LETTERS (2007)
Targeting lentiviral vectors to specific cell types in vivo
Lili Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes
Gregory S. Arnold et al.
MOLECULAR THERAPY (2006)
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
DM Roberts et al.
NATURE (2006)
Combinatorial engineering of a gene therapy vector:: directed evolution of adeno-associated virus
L Perabo et al.
JOURNAL OF GENE MEDICINE (2006)
Directed evolution of adeno-associated virus yields enhanced gene delivery vectors
N Maheshri et al.
NATURE BIOTECHNOLOGY (2006)
Adeno-associated virus serotypes: Vector toolkit for human gene therapy
Zhijian Wu et al.
MOLECULAR THERAPY (2006)
PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization
GK Lee et al.
BIOTECHNOLOGY AND BIOENGINEERING (2005)
Altering the tropism of lentiviral vectors through pseudotyping
J Cronin et al.
CURRENT GENE THERAPY (2005)
On the conservative nature of intragenic recombination
DA Drummond et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus
KH Warrington et al.
JOURNAL OF VIROLOGY (2004)
Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors
OJ Müller et al.
NATURE BIOTECHNOLOGY (2003)
Library analysis of SCHEMA-guided protein recombination
MM Meyer et al.
PROTEIN SCIENCE (2003)
Altering retroviral tropism using a random-display envelope library
K Bupp et al.
MOLECULAR THERAPY (2002)
Breeding of retroviruses by DNA shuffling for improved stability and processing yields
SK Powell et al.
NATURE BIOTECHNOLOGY (2000)
Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes
CL Halbert et al.
JOURNAL OF VIROLOGY (2000)
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism
P Wu et al.
JOURNAL OF VIROLOGY (2000)
分享论文
